Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jan
23
2017
Department Of Transportation To Add Synthetic Opioids To Its Drug Testing Panel Jackson Lewis P.C.
Jan
23
2017
Final Version of the Updated Coordinated Framework for the Regulation of Biotechnology Available Keller and Heckman LLP
Jan
23
2017
Sonny Perdue Chosen to Lead USDA; Organic Animal Welfare Rule Issued by USDA Squire Patton Boggs (US) LLP
Jan
23
2017
USDA Publishes Proposed Rule to Revamp Its Biotechnology Regulations Keller and Heckman LLP
Jan
23
2017
Increased Cooperation in Enforcement Activity: Italian Competition Authority and Italian Medicines Agency Sign Memorandum of Understanding McDermott Will & Emery
Jan
22
2017
EPA and FDA Issue Final Fish Consumption Advice U.S. Environmental Protection Agency
Jan
20
2017
Toxicity Data on Chemicals Found in Food Now Available on European Food Safety Authority Website Keller and Heckman LLP
Jan
20
2017
FDA Says Yes to Pre-Approval Communications with Payors but Reaffirms its Approach to Restrictions on Off-Label Communications Epstein Becker & Green, P.C.
Jan
20
2017
How Will Trump Change The FDA? Foley & Lardner LLP
Jan
19
2017
Summary of FDA Statement on Laboratory Developed Tests Issued January 13, 2017 Squire Patton Boggs (US) LLP
Jan
19
2017
2016 Year in Review: FDA Advertising & Promotion Enforcement Activity Covington & Burling LLP
Jan
19
2017
FDA Releases Draft Guidance to Help Sprout Operations Comply with Produce Safety Rule Keller and Heckman LLP
Jan
19
2017
National Institute for Occupational Safety and Health Accepting Input on How Best to Protect Workers, Including in Nanotechnology Bergeson & Campbell, P.C.
Jan
18
2017
FDA Issues Discussion Paper on Possible Regulatory Approach for Laboratory Developed Tests Covington & Burling LLP
Jan
18
2017
FDA Issues Final Guidance on Benefit-Risk for Investigational Device Exemptions Barnes & Thornburg LLP
Jan
18
2017
The Trump Administration’s View on Marijuana: Reading the (Tea) Leaves McDermott Will & Emery
Jan
18
2017
FDA to Hold Public Hearing on Partnerships to Enhance Safety of Imported Foods Keller and Heckman LLP
Jan
18
2017
340B Update: HRSA Finalizes 340B Pricing & Penalties for Drug Manufacturers K&L Gates
Jan
17
2017
Federal Circuit’s Eli Lilly Decision Clarifies the Direction or Control Standard in Dividend Infringement Michael Best & Friedrich LLP
Jan
17
2017
Massachusetts Has Legalized Marijuana — Should Your Workplace Policies Go Up in Smoke? Foley & Lardner LLP
Jan
17
2017
Supplement Spotlight: FDA Revised NDI Draft Guidance Does Not Alleviate Industry’s Concerns Keller and Heckman LLP
Jan
17
2017
FDA’s Enforcement Priorities Likely to Change in 2017 and Other “Unknowable Knowns” Mintz
Jan
17
2017
TTB Publishes Federal Register Notice Adjusting Civil Monetary Penalty under ABLA McDermott Will & Emery
Jan
17
2017
Medical Marijuana Comes to Pennsylvania: What to Expect As the Keystone State Rolls Out its New Medical Marijuana Program K&L Gates
Jan
17
2017
What Is The Trump Pharmaceutical Policy? Foley & Lardner LLP
Jan
16
2017
Regulating Commercial Food Activites: Be Fair, or the (Polish) Government Will Chase You! Squire Patton Boggs (US) LLP
Jan
16
2017
Two Important Decisions Addressing ANVISA’s Prior Approval of Pharmaceutical Patents in Brazil Michael Best & Friedrich LLP
Jan
16
2017
Supreme Court Will Judge Biosimilar Patent Dance Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins